CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 724814-724913 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T55535","span":{"begin":0,"end":99},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In the NT group, seven patients (27%) had an additional AID, in the SCLC group two (11%) ( p=0.20)."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T63","span":{"begin":0,"end":99},"obj":"Sentence"}],"text":"In the NT group, seven patients (27%) had an additional AID, in the SCLC group two (11%) ( p=0.20)."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T1405","span":{"begin":56,"end":59},"obj":"Phenotype"},{"id":"T1406","span":{"begin":68,"end":72},"obj":"Phenotype"}],"attributes":[{"id":"A1405","pred":"hp_id","subj":"T1405","obj":"http://purl.obolibrary.org/obo/HP_0002960"},{"id":"A1406","pred":"hp_id","subj":"T1406","obj":"http://purl.obolibrary.org/obo/HP_0030357"}],"text":"In the NT group, seven patients (27%) had an additional AID, in the SCLC group two (11%) ( p=0.20)."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T4546","span":{"begin":56,"end":59},"obj":"Disease"},{"id":"T4547","span":{"begin":68,"end":72},"obj":"Disease"},{"id":"T90797","span":{"begin":56,"end":59},"obj":"Disease"},{"id":"T57004","span":{"begin":68,"end":72},"obj":"Disease"}],"attributes":[{"id":"A4546","pred":"mondo_id","subj":"T4546","obj":"http://purl.obolibrary.org/obo/MONDO_0007179"},{"id":"A4547","pred":"mondo_id","subj":"T4547","obj":"http://purl.obolibrary.org/obo/MONDO_0008433"},{"id":"A15799","pred":"mondo_id","subj":"T90797","obj":"http://purl.obolibrary.org/obo/MONDO_0007179"},{"id":"A41335","pred":"mondo_id","subj":"T57004","obj":"http://purl.obolibrary.org/obo/MONDO_0008433"}],"text":"In the NT group, seven patients (27%) had an additional AID, in the SCLC group two (11%) ( p=0.20)."}